peramivir and Syndrome

peramivir has been researched along with Syndrome* in 2 studies

Other Studies

2 other study(ies) available for peramivir and Syndrome

ArticleYear
Successful Outcome in an Adult Patient with Influenza-associated Hemorrhagic Shock and Encephalopathy Syndrome.
    Internal medicine (Tokyo, Japan), 2020, Sep-15, Volume: 59, Issue:18

    A 50-year-old woman presented with coma and hemorrhagic shock. A rapid influenza antigen test revealed influenza A infection; other laboratory examinations ruled out any other suspected infections. She was diagnosed with hemorrhagic shock and encephalopathy syndrome (HSES) induced by influenza A. She was administered methylprednisolone pulse therapy and peramivir. Subsequently, she was discharged without any sequelae. Only a few cases of influenza-induced HSES have been reported, and the clinical outcomes were very poor. We herein report a successfully treated adult case of influenza-induced HSES and review this rare syndrome.

    Topics: Acids, Carbocyclic; Anti-Inflammatory Agents; Antiviral Agents; Blood Coagulation Disorders; Brain Diseases; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female; Guanidines; Humans; Influenza A virus; Influenza, Human; Methylprednisolone; Middle Aged; Shock, Hemorrhagic; Syndrome

2020
Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson's disease with improvement after intravenous peramivir treatment.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019, Volume: 40, Issue:6

    Topics: Acids, Carbocyclic; Administration, Intravenous; Aged; Antiparkinson Agents; Antiviral Agents; Cyclopentanes; Disease Progression; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Parkinson Disease; Syndrome

2019